SCHEMBL7791638

SCHEMBL7791638

C=CCc1cc(OC)ccc1Oc1ccc(OC)cc1CC=C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.54
ALDH1A1 P00352 3/20 0.52
TP53 P04637 1/20 0.52
CYP3A4 P08684 1/20 0.52
ALOX15 P16050 1/20 0.52
TSHR P16473 1/20 0.52
ALOX12 P18054 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
LMNA P02545 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
SLC2A1 P11166 1/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ALOX5 P09917 1/20 0.48
GABRA1 P14867 1/20 0.48
CNR2 P34972 1/20 0.48
GABRB2 P47870 1/20 0.48
TDP1 Q9NUW8 2/20 0.47
PPARG P37231 1/20 0.47
PPARD Q03181 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2848289 0.91 ALOX5 (0.56) MAPTALDH1A1TP53CYP3A4ALOX15
SCHEMBL2096402 0.83 ALDH1A1 (0.57) MAPTALDH1A1TP53CYP3A4ALOX15
SCHEMBL14957926 0.82 MAPT (0.62) MAPTALDH1A1TP53CYP3A4ALOX15
SCHEMBL2845262 0.80 APLNR (0.58) MAPTALDH1A1TP53CYP3A4ALOX15
SCHEMBL30105464 0.80 APLNR (0.58) MAPTALDH1A1TP53CYP3A4ALOX15
SCHEMBL29106728 0.79 MEN1 (0.41) MAPTALDH1A1TSHRSMN1; SMN2L3MBTL1
SCHEMBL9349817 0.79 ALDH1A1 (0.52) MAPTALDH1A1TP53CYP3A4ALOX15
SCHEMBL28326498 0.79 ALDH1A1 (0.52) MAPTALDH1A1TP53CYP3A4ALOX15
SCHEMBL335296 0.79 GABRA1 (0.59) MAPTALDH1A1TP53CYP3A4ALOX15
SCHEMBL3238750 0.78 L3MBTL1 (0.51) MAPTALDH1A1TP53ALOX12SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010014694-A1 Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin ENCYSIVE PHARMACEUTICALS, INC. 2001-08-16 US disclosed
US-6265428-B1 VASODILATION TEXAS BIOTECHNOLOGY CORPORATION 2001-07-24 US disclosed
US-5977117-A Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 1999-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010014694-A1 Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin EDNRA, EDNRB, NPR1 MAPT 4496/4885ALDH1A1 4421/4885TP53 4097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.